The table below shows MADRIGAL PHARMACEUTICALS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
-
$180.13M
$0.00
$0.00
$0.00
$0.00
Cost of revenue
-
$6.23M
$0.00
$0.00
-
-
Gross profit
-
-
-
-
-
-
R&D
-
-
-
-
-
-
SG&A
$813.83M
MDGL annual revenue (10-K history)
MADRIGAL PHARMACEUTICALS, INC. reported annual revenue of $958.40M for fiscal year 2025. That is up 432.1% from $180.13M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $147.00K (FY 2012) to $958.40M. Figures come from the company's audited annual reports as filed with the SEC.